Follow
Ian Winters
Ian Winters
Verified email at stanford.edu
Title
Cited by
Cited by
Year
Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing
SH Chiou, IP Winters, J Wang, S Naranjo, C Dudgeon, FB Tamburini, ...
Genes & development 29 (14), 1576-1585, 2015
2642015
A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo
ZN Rogers, CD McFarland, IP Winters, S Naranjo, CH Chuang, D Petrov, ...
Nature methods 14 (7), 737-742, 2017
1162017
Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice
ZN Rogers, CD McFarland, IP Winters, JA Seoane, JJ Brady, S Yoon, ...
Nature genetics 50 (4), 483-486, 2018
1122018
Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity
IP Winters, SH Chiou, NK Paulk, CD McFarland, PV Lalgudi, RK Ma, ...
Nature communications 8 (1), 2053, 2017
942017
An LKB1–SIK axis suppresses lung tumor growth and controls differentiation
CW Murray, JJ Brady, MK Tsai, C Li, IP Winters, R Tang, L Andrejka, ...
Cancer discovery 9 (11), 1590-1605, 2019
752019
RNA interference in marine and freshwater sponges: actin knockdown in Tethya wilhelma and Ephydatia muelleriby ingested dsRNA expressing bacteria
AS Rivera, JU Hammel, KM Haen, ES Danka, B Cieniewicz, IP Winters, ...
BMC biotechnology 11, 1-15, 2011
622011
Towards quantitative and multiplexed in vivo functional cancer genomics
IP Winters, CW Murray, MM Winslow
Nature Reviews Genetics 19 (12), 741-755, 2018
512018
Zmat3 is a key splicing regulator in the p53 tumor suppression program
KT Bieging-Rolett, AM Kaiser, DW Morgens, AM Boutelle, JA Seoane, ...
Molecular cell 80 (3), 452-469. e9, 2020
502020
The evolution and function of the Pax/S ix regulatory network in sponges
A Rivera, I Winters, A Rued, S Ding, D Posfai, B Cieniewicz, K Cameron, ...
Evolution & Development 15 (3), 186-196, 2013
422013
Tumor suppressor activity of Selenbp1, a direct Nkx2-1 target, in lung adenocarcinoma
DR Caswell, CH Chuang, RK Ma, IP Winters, EL Snyder, MM Winslow
Molecular Cancer Research 16 (11), 1737-1749, 2018
352018
Quantitative In Vivo Analyses Reveal a Complex Pharmacogenomic Landscape in Lung Adenocarcinoma
C Li, WY Lin, H Rizvi, H Cai, CD McFarland, ZN Rogers, M Yousefi, ...
Cancer research 81 (17), 4570-4580, 2021
162021
An LKB1–SIK axis suppresses lung tumor growth and controls differentiation. Cancer Discov. 2019; 9: 1590–1605. doi: 10.1158/2159-8290
CW Murray, JJ Brady, MK Tsai, C Li, IP Winters, R Tang, L Andrejka, ...
CD-18-1237.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0
13
Oncogenic context shapes the fitness landscape of tumor suppression
LM Blair, JM Juan, L Sebastian, VB Tran, W Nie, GD Wall, M Gerceker, ...
Nature Communications 14 (1), 6422, 2023
42023
Compositions and methods for multiplexed quantitative analysis of cell lineages
MM Winslow, D Petrov, IP Winters, C McFarland, ZN Rogers
US Patent 10,801,021, 2020
12020
21 CRISPR/Cas9-based In Vivo Models of Cancer
PV Lalgudi, MM Winslow, IP Winters
Genome editing and engineering: from TALENs, ZFNs and CRISPRs to molecular …, 2018
12018
Biomarkers for predicting responsiveness to mek inhibitor monotherapy and combination therapy
IP Winters, JBM Juan, M Rosen, MM Winslow, DA Petrov, GD Wall
US Patent App. 18/082,464, 2023
2023
Biomarkers for predicting responsiveness to shp2 inhibitor therapy
IP Winters, JBM Juan, MJ Rosen, MM Winslow, DA Petrov, GD Wall
US Patent App. 18/161,664, 2023
2023
An in vivo pharmacogenomics platform replicates and extends biomarkers of therapy response identified via causal inference analysis of clinical data
D Amar, E Scott, IP Winters, GD Wall, DA Petrov, MM Winslow, J Juan, ...
Cancer Research 83 (7_Supplement), 5723-5723, 2023
2023
Tumor suppressor genotype dramatically impacts lung cancer response to KRAS G12C inhibitors in vivo
PJ McMurdie, IP Winters, LM Blair, L Sebastian, V Tran, G Grenot, ...
Cancer Research 83 (7_Supplement), 2789-2789, 2023
2023
Analysis of 30 million tumor time course reveals that inactivating tumor suppressors produces complex gene-specific, time-dependent growth dynamics
AL Severson, J Juan, L Sebastian, V Tran, W Nie, I Lai, GD Wall, ...
Cancer Research 83 (7_Supplement), 11-11, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20